PMV Pharmaceuticals, Inc. (PMVP)
↓ Download CSVKey ratios (FY2025)
-74.2%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -$86.21M | -$85.45M | -$80.13M | -$77.04M | -$58.29M | -$34.94M | -$26.64M | -$18.89M | — |
| Net Income | -$77.74M | -$58.71M | -$68.96M | -$73.32M | -$57.85M | -$34.44M | -$25.35M | -$17.54M | — |
| EPS (Diluted) | $-1.48 | $-1.14 | $-1.44 | $-1.61 | $-1.28 | $-2.40 | — | — | — |
| Total Assets | $116.56M | $191.29M | $252.15M | $270.31M | $331.57M | $365.53M | $103.03M | — | — |
| Total Liabilities | $11.85M | $15.21M | $26.46M | $24.28M | $23.01M | $6.41M | $4.57M | — | — |
| Shareholders' Equity | $104.71M | $176.08M | $225.69M | $246.03M | $308.56M | $359.12M | -$70.47M | -$46.14M | -$29.73M |
| Cash & Equivalents | $37.98M | $40.88M | $37.71M | $108.30M | $172.47M | $361.42M | $73.28M | — | — |
| Operating Cash Flow | -$73.58M | -$51.28M | -$55.66M | -$63.76M | -$46.57M | -$32.74M | -$22.07M | -$15.18M | — |
| Capital Expenditures | $29.0K | $655.0K | $962.0K | $7.98M | $1.35M | $148.0K | $109.0K | $452.0K | — |
| Shares Outstanding | 53.33M | 51.94M | 51.45M | 45.77M | 45.43M | 44.78M | 3.05M | — | — |